Pharmafile Logo

NEW WEBINAR! From Clicks to Outcomes: Measuring the Impact of Your Medical Education Platform

Struggling to quantify the value of your medical education platform and prove its ROI? Join our upcoming Pharma-exclusive webinar to learn real-work strategies and tips for developing a Med Ed platform that provides real results! You’ll learn real-world best practices on everything from design and content to tracking and engagement.

- PMLiVE

About the webinar

Tired of building medical education programs that fail to deliver? Impetus Digital invites you to our free webinar on May 13 and 14, designed specifically for life science professionals who are ready to build a medical education platform that truly engages HCPs and drives measurable results.

This transformative webinar will reveal the key components of a successful platform, showcasing innovative strategies and technologies such as modular activities, immersive educational mini-series, interactive simulations, gamification, and more!

Register today and be at the forefront of learning. Among other topics, our expert speaker will cover how to:

  • Maximize your Med Ed ROI: Discover how to build a platform that delivers measurable results and demonstrates its value to your organization.
  • Measure Outcomes: Gain expert insights on how to track and measure the real impact of your educational initiatives across various metrics.
  • Avoid Costly Mistakes: Learn from the mistakes of other industry professionals and avoid common pitfalls that can hinder the success of your platform.
  • Effectively Engage and Educate HCPs: Create a platform that truly engages HCPs and drives measurable impact.
  • And that’s just the beginning— we’ll showcase much more!

 

Can’t make one of the live webinars? Sign up anyway, and we will follow up with you directly!

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Beat inflation with virtual meetings and programs

At the time of writing, the average inflation rate worldwide sits at 7.4%, the highest it’s been for decades. Here in Canada, the inflation rate is not forecasted to come back down...

Engaging KOLs & Gaining Insights in Pharma’s New Normal

Kaitlin Anstett, Senior Medical Advisor at Theratechnologies, shares her unique insights into the way Medical Affairs teams are changing the way they are engaging and interacting with their most important...

There’s No Going Back: How COVID-19 will Change Pharma Forever

Munther Baara, VP Product Strategy and Innovation at EDETEK, discusses all things clinical trials. Especially, we discuss the current gaps and the impact of COVID-19 on the way Pharma approaches...

Powering Rapid Cognitive Analysis with AI

Dr. Tom Sawyer, CFO at Cognetivity Neurosciences, discusses the benefits of AI-driven dementia detection technology for patients, health care providers, and clinical research.

KOL Ambassador Program & Podcast Creation: A Customer Story

Leveraging Impetus Digital’s best-in-class synchronous (real-time) and asynchronous (over-time, anytime) tools, our client facilitated a virtual ambassador program with three oncologist key opinion leaders (KOLs) from South Korea.The client’s main objectives...

Importance of Emotional Intelligence in Pharma and Medical Affairs

Emma Lynch, Founder of EQ Vibration & Quadrant 2 Medical, explores a number of interesting topics related to Medical Affairs. Among many other things, she discusses the importance of emotional...

Virtual product launch planning: the ultimate playbook

We walk you through, step-by-step, how cross-functional teams can seamlessly work together and overcome the many obstacles associated with traditional product launches.

Artificial Intelligence for Identifying and Monitoring Cognitive Decline

Liam Kaufman, CEO & Co-founder of Winterlight Labs, explores a range of topics related to AI, machine learning, natural language processing, digital biomarkers, and human-computer interactions in healthcare.

Trust and transparency in Pharma & healthcare: impact of the COVID-19 pandemic

While it is obvious that trust in life science and healthcare companies is suboptimal, exactly how to improve the public’s trust is unclear...